The MedSafer Study: A Controlled Trial of an Electronic Decision Support Tool for Deprescribing in Acute Care
Emily G. McDonald(McGill University Health Centre), Todd C. Lee(McGill University Health Centre), Sandra Porter(University Health Network), Babak Rashidi(University of Ottawa), André Bonnici(McGill University Health Centre), Robyn Tamblyn(McGill University Health Centre), James Downar(University of Toronto), Alan J. Forster(University of Ottawa), Kiran Battu(University Health Network), Allen Huang(Ottawa Hospital), Peter E. Wu(University Health Network), Louise Papillon‐Ferland(Institut Universitaire de Gériatrie de Montréal), Rachel Whitty(University of Toronto), Louise Pilote(McGill University Health Centre)
Cited by 88
Related Papers
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
|New England Journal of Medicine|2020|1.4k
Predatory journals: no definition, no defence
|Nature|2019|716
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19
|Annals of Internal Medicine|2020|548
Comparison of Saliva and Nasopharyngeal Swab Nucleic Acid Amplification Testing for Detection of SARS-CoV-2
|JAMA Internal Medicine|2021|327
Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis
|Clinical Microbiology and Infection|2022|287